Thursday July 24, 7:00 am ET SAN DIEGO–(BUSINESS WIRE)–Aethlon Medical, Inc. (OTCBB:AEMD - The paper entitled, “Exosomes as a Tumor Immune Escape Mechanism: Possible Therapeutic …

See original here:
aethlon, aethlon-medical, Avian Flu, Bird Flu, business, cancer-therapy, entertainment, epidemic, immunotherapy, infections, influenza, iphone, News, pharmaceuticals, politics, technology, tour-de-france

Related posts

• Cancer Treatment Application of the Aethlon Hemopurifier(R … (0)
• Promising New Human H5N1 Flu Vaccine (0)
• Aethlon Medical Announces Second HIV/AIDS Treatment Site (0)
• Aethlon Medical Announces Cancer Treatment License (0)
• World warned over killer flu pandemic… (0)